GoodRx Holdings (GDRX) Net Cash Flow (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Net Cash Flow data on file, last reported at -$26.1 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 82.28% year-over-year to -$26.1 million; the trailing twelve-month figure through Mar 2026 stood at -$65.3 million (up 71.9% YoY), and the FY2025 full-year result was -$186.5 million, up 16.71% from the prior year.
• Net Cash Flow retreated to -$26.1 million in Q1 2026, from -$11.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $32.9 million in Q3 2023 to a low of -$147.4 million in Q1 2025.
• A 5-year average of -$41.5 million and a median of -$11.7 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 1976.68% in 2023 and plunged 3655.01% in 2024, its largest moves.
• Tracing GDRX's Net Cash Flow over 5 years: stood at $28.4 million in 2022, then sank by 532.04% to -$122.6 million in 2023, then jumped by 120.04% to $24.6 million in 2024, then slumped by 147.66% to -$11.7 million in 2025, then plunged by 122.99% to -$26.1 million in 2026.
• Business Quant data shows GDRX's Net Cash Flow at -$26.1 million in Q1 2026, -$11.7 million in Q4 2025, and -$7.8 million in Q3 2025.